| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 155.077 | 191.050 | 174.663 | 123.166 | 209.201 | 160.397 | 243.747 |
| Total Income - EUR | - | - | - | 156.126 | 193.796 | 176.127 | 123.477 | 210.308 | 161.321 | 245.059 |
| Total Expenses - EUR | - | - | - | 30.647 | 60.589 | 61.924 | 63.066 | 96.901 | 88.141 | 138.770 |
| Gross Profit/Loss - EUR | - | - | - | 125.479 | 133.207 | 114.203 | 60.411 | 113.407 | 73.180 | 106.289 |
| Net Profit/Loss - EUR | - | - | - | 123.925 | 131.274 | 112.785 | 59.201 | 111.356 | 71.814 | 100.501 |
| Employees | - | - | - | 7 | 7 | 7 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Send 92 Terapii Alternative S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 46 | 41 | 24 | 34 | 13 | 11 | 1.020 |
| Current Assets | - | - | - | 127.123 | 136.435 | 115.914 | 81.103 | 212.714 | 97.676 | 174.333 |
| Inventories | - | - | - | 6.586 | 12.919 | 20.444 | 19.212 | 23.923 | 29.626 | 52.269 |
| Receivables | - | - | - | 1.139 | 12.725 | 11.965 | 18.117 | 100.703 | 13.131 | 97.487 |
| Cash | - | - | - | 119.399 | 110.791 | 83.505 | 43.775 | 88.088 | 34.640 | 22.416 |
| Shareholders Funds | - | - | - | 123.976 | 131.324 | 112.834 | 59.250 | 111.405 | 81.799 | 111.481 |
| Social Capital | - | - | - | 52 | 51 | 50 | 49 | 49 | 49 | 48 |
| Debts | - | - | - | 3.210 | 5.152 | 3.197 | 21.918 | 101.359 | 15.915 | 63.895 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Send 92 Terapii Alternative S.r.l.